Glen Eagle Advisors, LLC Atai Life Sciences N.V. Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 166 shares of ATAI stock, worth $192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166Holding current value
$192% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
99Shares Held
12.7MCall Options Held
9.2KPut Options Held
118K-
Walleye Capital LLC Plymouth, MN2.76MShares$3.2 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.72MShares$3.15 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.52 Million0.0% of portfolio
-
Brown University719KShares$833,4600.39% of portfolio
-
Two Sigma Investments, LP New York, NY717KShares$831,8710.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $192M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...